| WE K NOW WHAT OUR CURRENT RE S E ARCH PRIORITIE S ARE
The priorities that AYA research is specifically seeking to address for patients and professionals are increasingly defined. Of course, AYA research teams must contribute to key themes across cancer care
such as "what is the best treatment for my cancer," "how can we ensure fewer people develop cancer." A US team has recently reviewed AYA-specific research priorities for the coming years, including care as well as diagnosis and treatment (Smith et al., 2016) . Australian and Canadian colleagues have recently produced policy in AYA health service care which speak to research 1 . The UK has recently undertaken a research priority setting exercise 2 , in collaboration with the James Lind Alliance (JLA). This included the following: creating a multidisciplinary steering group of all involved in AYA cancer care
including young people at all stages. The project gathered potential research questions from young people, carers and professionals online; checked submitted questions to ensure they were unanswered;
and two phases of prioritisation. Agreement was reached on the Top 10 research priorities (Table 1) . To reach these, a total of 855 potential questions were gathered from 292 respondents; refined into 208 unique questions. Seven were already answered and 16 were the focus of ongoing studies and very positively could be removed from our immediate future priorities. One hundred and seventy-four respondents prioritised these to 30 top questions. A final consensus workshop attended by 25 young people, carers and professionals from a broad range of roles finalised the top 10.
The central themes expressed here, along the AYA cancer timeline, have been known for many years (Lewis, 1996) . There is clearly a need for AYA-specific biologically driven research. Examples include to improve early and late adverse effects specific to AYA (Henson et al., 2016; Kremer et al., 2013; Rugbjerg & Olsen, 2016) , and to target treatments to the personal biology of the young person (Gaspar et al., 2018; Hughes & Stark, 2018) . However, the majority of the research priorities identified in the JLA priority setting exercise relate to improving care and support. Adolescent and young adult cancer research is therefore an excellent "home" for the ambitious and talented cancer care researcher.
| WE S HOULD DE S I G N AND IMPLEMENT INTERVENTI ON S TUD IE S IN OUR PRI ORIT Y ARE A S
What is also apparent from comparing current programmatic AYA research with "the JLA" is that much current research activity remains descriptive and observational. There is increasing pressure for interventional research and this is accompanied by an increasing desire from patients, funders and professionals for research to improve outcomes, rather than continuing to describe need, compare with others and call for action. We should now extend our work in these well-described themes to intervention; to scientifically test changes that we rigourously assess have strong potential to improve care and its outcomes. This has indeed required detailed characterisation of the specific similarities and differences between AYA and older/younger patients, over and above merely highlighting them, but much of that is now in place. For example 1. Specific barriers to AYA entering clinical trials are now characterised (Fern, Lewandowski, Coxon, & Whelan, 2014) 2. Patient and health service organisational factors that underpin advanced disease at AYA cancer presentation are increasingly understood (Herbert et al., 2018) 3. Biological differences between apparently similar cancers in AYA and other age groups are described in some areas (Tricoli et al., 2016) 4. The specific healthcare professional competencies required for working with AYA are characterised (Taylor et al., 2016) 5. The social difficulties of AYA with cancer are specifically and systematically described (Warner et al., 2016) .
6. The unmet needs of AYA have been frequently described and differ relatively little during the cancer trajectory (Lea et al., 2018) .
In this edition, Sodergren et al comprehensively describe how specific AYA needs can influence the quality of life (Sodergren et al., 2018) .
| WE NEED TO REMAIN S PECIFI C IN OUR RE S E ARCH TO THE DE TAIL S OF AYA C AN CER
Another key feature-true specificity to AYA issues-is steadily pervading cancer research. One way to achieve this in the 21st Century is large-scale population-based cohort studies, which can now widely be done with existing data. Once risks of adverse outcomes are described however, appropriate more detailed studies are essential to provide the AYA-specific characterisation of those risks and steer us to the most effective intervention. One biological example is that we now know after radiotherapy as an AYA for a brain tumour, by age 60 the risk of admission to hospital with a stroke is almost 10%, where the general population expected level is around 2.5% (Bright et al., 2017) . Case-control studies with patients can now identify which treatment, genetic and lifestyle factors are leading to these substantially increased health problems. Then, we can intervene specifically for AYA and expect our intervention to improve health.
| WE NEED TO K EEP AYA WITH C AN CER AT OUR CENTRE
Core to the success of AYA oncology, and complex interventions in particular, has been placing young people at the heart of research, from the point of theoretical modelling to intervention development. One excellent feature of this special edition of the European Journal of Cancer Care is the specific focus upon young people.
The studies here, in the main, have young people at their heart, characterising the specific similarities and differences between AYA and older or younger patients. The projects presented are contributing to the AYA cancer care research endeavour overall, such as the challenges of outcome measurement (Galán, de la Vega, & Miró, 2018 ) and the impact upon families (Hsiao et al., 2018) . This evidence also contributes to the development of interventions that are AYA-specific.
| WE NEED TO US E THE S PECIFI C ME THODS FOR COMPLE X INTERVENTI ON S IN OUR AYA INTERVENTI ON RE S E ARCH TO IMPROVE OUTCOME S IN OUR PRI ORIT Y ARE A S
The focus of this edition of this journal is upon AYA cancer care specifically. Here, our interventions often involve seeking to change the behaviour of clinicians (or any human) who provide or receive that care. This can be obviously, and technically, be described as "complex" (Campbell et al., 2000) . The success of these interventions relies upon the development of an even closer collaboration between the research community, patients and clinical practice. This is to ensure the scientific rigor with which the intervention is developed is not only specific and works, but is also in keeping with the way healthcare professionals work in practice or is acceptable to young people as a change in practice. The UK Medical Research Council (MRC) continues to provide updated and clear guidance on how such complex interventions should be developed 3 .
| WE NEED TO DE VELOP RE S E ARCH ON L ARG ER SC ALE IN AND MORE VARIED COLL ABOR ATIONS
One very enjoyable way to accelerate intervention research is to embed formative studies within the infrastructure of an international clinical trial. One example would be the AYA-Hears study examining treatment-related hearing loss from multiple perspectives within the AGCT1531 germ cell tumour clinical trial 4 . Clinical care interventions in psychosocial well-being or survivorship could also proceed faster in this manner, recruit a larger and more representative patient group and on completion already be developed alongside clinical teams to enhance the subsequent intervention trial.
Timely consideration of the priorities of healthcare providers, commissioners and policy is critical. This is largely achieved by embedding specific outcome variables that matter to them. Then, once we have shown interventions work, patients can receive them more equitably. If our research does not get converted into health services, sometimes that is because of our decisions during our research. As we mature as a speciality there are increasing opportunities, enthusiasm, confidence and demand for wider cooperation and a reducing need for stand-alone smaller scale studies, which may not be designed with a vision of a future intervention, and not developed alongside research groups with the reach to deliver intervention trials. The AYAspecific charitable funders contribute hugely to the infrastructure of clinical AYA services, but do not have the resources to fund such largescale intervention trials that can fulfil the regulatory requirements for health service adoption. Coalescing our community's approach around the key set of issues through such as "the JLA" has already begun to attract the attention of larger-scale funders. The building of even larger multi-professional, multi-centre, international research communities will be necessary to achieve intervention trial funding.
| CON CLUS ION
It is fabulous to have a special edition of the journal dedicated to bringing together AYA research into cancer care. This can only serve to further develop the relationships and academic collaborations required to develop and deliver large-scale intervention research and through that to improve the outcomes of AYA with cancer. To deliver for young people, we must create ever more spaces where we can design and implement that research together; professionals whose focus is upon care, diagnosis, treatment, research methodologists, working with young people and the public, to develop faster and more effective research. We are closing in upon an era of mature research in AYA oncology, becoming evidenced in our services, and running AYA-specific interventional studies that make a real difference. 
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